Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 116 - USE OF RADIONUCLIDES IN THE HEALING ARTS › Section 333-116-0380 - Imaging and Localization: Safety Precautions

Current through Register Vol. 63, No. 7, July 1, 2024
(1) For each patient or human research
			 subject receiving radiopharmaceutical therapy and hospitalized for compliance
			 with OAR 333-116-0260  or 333-116-0190, a licensee must:
(a) Provide a private room with a private
			 sanitary facility;
(b) Post the
			 door with a "Caution: Radioactive Material" sign and note on the door or on the
			 patient's chart where and how long visitors may stay in the patient's
			 room;
(c) Authorize visits by
			 individuals under age 18 only on a case-by-case basis with the approval of the
			 authorized user after consultation with the Radiation Safety Officer;
(d) Promptly after administration of the
			 dosage, measure the dose rates in contiguous restricted and unrestricted areas
			 with a radiation measurement survey instrument to demonstrate compliance with
			 the requirements of OAR 333-120-0180  of these rules and retain until inspection
			 by the Authority a record of each survey that includes the time and date of the
			 survey, a plan of the area or list of points surveyed, the measured dose rate
			 at several points expressed in mrem per hour, the instrument used to make the
			 survey and the initials of the individual who made the survey;
(e) Either monitor material and items removed
			 from the room to determine that any contamination cannot be distinguished from
			 the natural background radiation level with an appropriate radiation detection
			 survey instrument set on its most sensitive scale and with no interposed
			 shielding, or handle materials and items as radioactive waste;
(f) Instruct the patient or human research
			 subject and, where appropriate, the individual's family, orally and in writing
			 concerning radiation safety precautions that will help to keep radiation dose
			 to household members and the public as low as reasonably achievable before
			 authorizing release of the individual;
(g) Survey the room and private sanitary
			 facility for removable contamination with an appropriate radiation detection
			 survey instrument before assigning another patient to the room. The room must
			 not be reassigned until removable contamination is less than 33.3 Bq (2000 dpm)
			 per 100 square centimeters; and
(h)
			 Measure the thyroid burden of each individual who helped prepare or administer
			 a liquid dosage of iodine-131 within three days after administering the dosage.
			 A record of each thyroid burden measurement must be retained in accordance with
			 OAR 333-120-0650  of these rules. Each record must contain the date of
			 measurement, the name of the individual whose thyroid burden was measured, the
			 calculated thyroid burden, the effective dose equivalent, the name of the
			 individual who made the measurements and the signature of the Radiation Safety
			 Officer. Other procedures acceptable to the Authority may be used for
			 individuals who only prepare, but do not administer, doses of stabilized
			 I-131.